Our infection prevention
solutions reduce the risk of
infections, increase patient
safety and reduce the use of
antibiotics.
Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces. The active substance hypochlorous acid (HOCl) is a part of the human immune system. Hydrocyn® aqua kills:
Hydrocyn® aqua is proven effective against the SARS-CoV-2 virus that causes COVID-19 and against previous strains of coronavirus.
A recently published, randomized, controlled multicenter study including 1000 patients shows that urinary catheters with Bactiguard’s coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69 % compared to standard catheter.
A recent Italian publication has studied hospital-acquired infections (HAI) in 774 critically ill COVID-19 patients. The publication shows that 46 % of the patients developed HAI, of which most common HAIs were VAP and CRBSI.
Bactiguard’s Annual Report 2020 is now available for downloading in both Swedish and English. Find out about Bactiguard’s significant strategic advances and how we stand stronger than ever, ready to impact and drive change within infection prevention. Both in healthcare and in people’s everyday life.
Bactiguard Holding AB (publ) published the year-end report for 2020 on Thursday, February 4, 2021 at 8:00 CET.
The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.
The BIP Foley TempSensor is an indwelling urinary catheter which combines continuous temperature monitoring with Bactiguard’s infection prevention technology.
Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces, proven effective against the new coronavirus SARS-CoV-2.
